In the previous study, we examined the effects of TGF-βRI kinase inhibitor on the expression of p-SMAD2, tumor size, and cell proliferation [17], and we compared the tumor cells at the bone-interface with those in the area far away from the bone but within the same tumor. This evidence concerns the gene SMAD2 and neoplasm.